Strategic partnerships My Gene Counsel has a track record of forming strategic partnerships with clinical and digital health players (N-Power Medicine, FamGenix, Pacific Cancer Care) to expand genetic risk assessment, education, and testing adoption – representing collaboration opportunities with hospitals, clinics, and health systems seeking integrated genetic counseling capabilities.

Precision medicine growth Recent launches of precision medicine pilots and expanded genetic testing integration indicate a strong momentum toward guideline-based risk assessment and testing workflows, suggesting opportunities to position My Gene Counsel as the preferred digital genetics partner for oncology, hereditary cancer programs, and risk-stratified care pathways.

Clinical workflow integration Partnerships focused on embedding automated risk assessment and patient education into clinical workflows imply demand for turnkey integration with EHRs and practice management systems, offering a path to sell interoperability features and implementation services to health systems and ambulatory networks.

Digital education leadership The company specializes in translating complex genetic information into understandable consumer-focused content, presenting a sales angle to healthcare providers and payers around patient education tools, consent-ready education modules, and standardized genetic risk communication materials.

SMB and mid-market potential With a mid-sized employee base and revenue in the tens of millions, there is opportunity to target mid-market clinics, regional cancer centers, and urgent care networks looking to scale genetic counseling and testing programs without large enterprise commitments.